The American healthcare system is a paternalistic relic designed to profit from complexity, but Andrew Dudum is using a public-market 'bootcamp' to dismantle it. By cutting GLP-1 prices by 80% and verticalizing at-home blood testing, Hims & Hers is shifting the model from reactive sick-care to a proactive, transparent partnership. The secret isn't just in the tech—it's in a venture-style portfolio of bets and a team hired for raw grit over corporate credentials.